Atea Pharmaceuticals (AVIR) Change in Account Payables: 2018-2024
Historic Change in Account Payables for Atea Pharmaceuticals (AVIR) over the last 7 years, with Dec 2024 value amounting to $206,000.
- Atea Pharmaceuticals' Change in Account Payables rose 108.12% to $1.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$2.0 million, marking a year-over-year decrease of 119.27%. This contributed to the annual value of $206,000 for FY2024, which is 87.89% down from last year.
- According to the latest figures from FY2024, Atea Pharmaceuticals' Change in Account Payables is $206,000, which was down 87.89% from $1.7 million recorded in FY2023.
- Over the past 5 years, Atea Pharmaceuticals' Change in Account Payables peaked at $10.3 million during FY2021, and registered a low of -$2.0 million during FY2022.
- For the 3-year period, Atea Pharmaceuticals' Change in Account Payables averaged around -$25,333, with its median value being $206,000 (2024).
- Its Change in Account Payables has fluctuated over the past 5 years, first plummeted by 410.83% in 2020, then surged by 2,208.40% in 2021.
- Yearly analysis of 5 years shows Atea Pharmaceuticals' Change in Account Payables stood at -$488,000 in 2020, then soared by 2,208.40% to $10.3 million in 2021, then plummeted by 119.27% to -$2.0 million in 2022, then skyrocketed by 185.78% to $1.7 million in 2023, then tumbled by 87.89% to $206,000 in 2024.